History
  • No items yet
midpage
443 F. App'x 58
6th Cir.
2011
Read the full case

Background

  • Plaintiffs Thomas, Melau, and Anderson sued Novartis alleging Zometa/Aredia caused osteonecrosis of the jaw.
  • MDL proceedings were transferred to the Middle District of Tennessee for consolidated handling.
  • District court granted summary judgment to Novartis and barred treating physicians from offering expert testimony on specific causation.
  • Plaintiffs sought to use non-retained treating-physician testimony to prove specific causation; the district court excluded it.
  • Court discusses Daubert, Rule 702, and gatekeeping and applies it to assess the treating physicians’ reliability.
  • Court affirms district court’s rulings and hence grants summary judgment for Novartis on all cases.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Can treating physicians testify on specific causation? Thomas argues treating doctors are qualified to opine. Novartis contends they lack reliability/fit for specific causation. No abuse; treating opinions not shown reliable under Daubert/Rule 702.
Did Dr. Johnson’s opinion meet Rule 702 requirements? Thomas relied on Dr. Johnson’s experience. Johnson’s experience did not establish reliability for causation. Not established; district court did not err in exclusion.
Was summary judgment proper without admissible specific causation evidence? Evidence other than treating opinions could raise fact questions. No admissible specific-causation evidence; no triable issue. Yes; summary judgment proper.
Was Melau’s preservation issue fatal to appeal argument about non-retained evidence? Melau raised argument on appeal Argument not preserved in district court. Argument not considered on appeal.

Key Cases Cited

  • Tamraz v. Lincoln Elec. Co., 620 F.3d 665 (6th Cir. 2010) (Daubert gatekeeping and reliability standards for expert testimony)
  • Ky. Speedway, LLC v. Nat’l Assoc. of Stock Car Auto Racing, Inc., 588 F.3d 908 (6th Cir. 2009) (Broad discretion to district courts on admissibility decisions)
  • In re Scrap Metal Litig., 527 F.3d 517 (6th Cir. 2008) (Admissibility and reliability considerations in expert testimony)
  • Nolan v. Memphis City Sch., 589 F.3d 257 (6th Cir. 2009) (Deference to district court on evidentiary rulings; standard of review)
  • Gass v. Marriott Hotel Servs., Inc., 558 F.3d 419 (6th Cir. 2009) (Treating-physician testimony analysis under Daubert)
  • Fielden v. CSX Transp., Inc., 482 F.3d 866 (6th Cir. 2007) (Treating-witness reliability and expert testimony standards)
  • Best v. Lowe’s Home Ctrs., Inc., 563 F.3d 171 (6th Cir. 2009) (Expert testimony foundation and methodological reliability)
Read the full case

Case Details

Case Name: Terry Anderson v. Novartis Pharmaceuticals Corp
Court Name: Court of Appeals for the Sixth Circuit
Date Published: Aug 23, 2011
Citations: 443 F. App'x 58; 09-6147, 09-6272, 09-6274
Docket Number: 09-6147, 09-6272, 09-6274
Court Abbreviation: 6th Cir.
Log In
    Terry Anderson v. Novartis Pharmaceuticals Corp, 443 F. App'x 58